PeptiDream has been granted a patent for a method to produce peptides involving condensing protected amino acids and removing protective groups. The process aims to streamline peptide synthesis for potential applications in drug development and biotechnology. GlobalData’s report on PeptiDream gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights PeptiDream Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on PeptiDream, Cyclosporin derivatives was a key innovation area identified from patents. PeptiDream's grant share as of May 2024 was 10%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11993629B2) discloses a method for producing peptides involving specific steps. The method includes condensing C-protected amino acids or peptides with N-protected amino acids or peptides, followed by repeating the condensation and deprotection steps. The obtained peptides are purified using liquid separation techniques with either acidic or basic aqueous solutions. The protective groups used in the process include alkyl groups and alkylsilyl groups, with specific conditions for condensation and deprotection outlined in the claims.

Furthermore, the patent details the use of various condensation agents and bases in the process, along with specific deprotection conditions involving different agents such as water, acids, and fluorine compounds. Additional steps for removing protective groups at the N-terminal of peptides are also described, along with further condensation and deprotection steps. The patent emphasizes the importance of the R1R2R3Si group in the protective groups used, with specific carbon atom ranges and configurations specified for optimal peptide production. Overall, the method outlined in the patent provides a detailed and systematic approach to peptide synthesis, ensuring the efficient and controlled production of peptides with specific protective groups and purification techniques.

To know more about GlobalData’s detailed insights on PeptiDream, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies